Environment

Manager, EH&S - Emergent BioSolutions - San Diego, CA

7 days ago   |   By San Diego Biotechnology

May act as Biosafety Officer for this Biotechnology division. Minimum 3 years work experience in the Biotechnology environment. May act as Biosafety Officer.From Emergent BioSolutions - Wed, 04 Dec 2019 00:59:05 GMT - View all San Diego, CA jobs...
Read more ...

 

Accounts Payable Specialist - Arena Pharmaceuticals - San Diego, CA

7 days ago   |   By San Diego Biotechnology

We are seeking an experienced candidate who can assign invoices to the proper GL and cost centers, work with vendors to resolve past due invoices and reconcile...From Arena Pharmaceuticals - Wed, 04 Dec 2019 00:53:38 GMT - View all San Diego, CA jobs...
Read more ...

 

Compliance Specialist - Neurocrine Bioscience - San Diego, CA

7 days ago   |   By San Diego Biotechnology

This position reports to Chief Compliance Officer and supports the development, implementation, execution and continuous improvement of the Neurocrine...From Neurocrine Bioscience - Wed, 04 Dec 2019 00:10:16 GMT - View all San Diego, CA jobs...
Read more ...

 

Sr Manager, Software Development - Illumina - San Diego, CA

7 days ago   |   By San Diego Biotechnology

Experience in biotech is also a plus, as is experience with developing software to FDA clinical standards. This role fills a critical leadership position in the...From Illumina - Wed, 04 Dec 2019 00:11:25 GMT - View all San Diego, CA jobs...
Read more ...

 


Search by Tags

   Environment      BioTechnology      San Diego Biotech Jobs      Jobs      Pharmaceutical      Pharmaceuticals      Biosciences      Clinical      Biotech      BioTech  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Perceptive Unveils New $200M Fund to Invest in Early-Stage Biotechs

Perceptive Unveils New $200M Fund to Invest in Early-Stage Biotechs

Perceptive Advisors, an investment firm with a long track record of life science investing across all points of development, is now stepping up to pump money into companies at... Read more ...

Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule

Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule

Merck is acquiring cancer drug developer ArQule for $2.7 billion , a cash deal that brings it a promising early-stage compound that could challenge a blockbuster leukemia drug... Read more ...

KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test

KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test

A KalVista Pharmaceuticals eye drug at the center of a research collaboration with Merck has failed a mid-stage clinical trial. KalVista developed its drug, KVD001, to treat... Read more ...

Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules

Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules

Zentalis Pharmaceuticals is banking on small molecules for cancer-leaving the “cool technologies” aside for a “tried and true” approach, says the CEO, who wants to let the... Read more ...

Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer

Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer

The Scripps Research Institute and AbbVie have agreed to broaden an existing drug discovery agreement focused on cancer cell therapies to now encompass treatments for other... Read more ...

Eying Cancer Combos, Sanofi to Splash Out $2.5B on San Diego's Synthorx

Eying Cancer Combos, Sanofi to Splash Out $2.5B on San Diego's Synthorx

Synthorx is working to design new cytokine therapies for cancer using an “extended” genetic alphabet that could help avoid the shortcomings associated with earlier versions... Read more ...

Artificial Pancreas Keeps Patients Healthier: A Perspective

Artificial Pancreas Keeps Patients Healthier: A Perspective

The late Mayo endocrinologists Russell Wilder, M.D., and Randall Sprague, M.D., would be smiling today at the news for patients with diabetes. Much of their lives and careers... Read more ...

Aurinia Plans FDA Filing After Lupus Nephritis Drug Hits Phase 3 Goals

Aurinia Plans FDA Filing After Lupus Nephritis Drug Hits Phase 3 Goals

Aurinia shares spiked last week after voclosporin, an immunosuppressant being tested in patients with lupus nephritis, met its primary and secondary endpoints in a Phase 3... Read more ...

AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets

AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets

After joining AstraZeneca's Boston Bio Hub incubator last year, Gatehouse Bio is now teaming up with the pharma company to identify potential drug targets in respiratory and... Read more ...

Interactive effects of nitrogen fertilizer and altered precipitation on...

Abstract Purpose Fungi play an essential role in regulating the functioning of terrestrial ecosystems and are sensitive to climate change factors. Climate change incidents... Read more ...